trending Market Intelligence /marketintelligence/en/news-insights/trending/zbas0dc9vpdgqgmjxxt8hg2 content esgSubNav
In This List

Sarepta Therapeutics adds director

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Sarepta Therapeutics adds director

Sarepta Therapeutics Inc. has appointed Mary Ann Gray to the board.

Gray is president of Gray Strategic Advisors LLC, a biotechnology strategic planning and advisory firm. Previously, she was on the boards of Senomyx Inc., Juniper Pharmaceuticals Inc., TetraLogic Pharmaceuticals Corp. and ACADIA Pharmaceuticals Inc.

Cambridge, Mass.-based Sarepta Therapeutics focuses on the discovery and development of RNA-based therapeutics, gene therapy and other genetic medicine approaches for treating rare neuromuscular diseases.